{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T05:52:10Z","timestamp":1794808330928,"version":"4.9.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G035024N"],"award-info":[{"award-number":["G035024N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004497","name":"Onderzoeksraad, KU Leuven","doi-asserted-by":"publisher","award":["C3\/20\/090"],"award-info":[{"award-number":["C3\/20\/090"]}],"id":[{"id":"10.13039\/501100004497","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04350-0","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T11:11:30Z","timestamp":1776856290000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Monocyte-hitchhiking system for the targeted delivery of paclitaxel-loaded PLGA nanoparticles to glioblastoma in mice"],"prefix":"10.1186","volume":"24","author":[{"given":"Xanthippi","family":"Koutsoumpou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Lenders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshaya Lakshmi","family":"Krishnamoorthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ine","family":"Vlaeminck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jef","family":"Rozenski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floriana","family":"De Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla Rios","family":"Luci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipa Roque","family":"Goncalves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermon","family":"Girmatsion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Ciwinksa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Nobis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colinda L. G. J.","family":"Scheele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefaan J.","family":"Soenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"De Vleeschouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bella B.","family":"Manshian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"4350_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.01.012","author":"TI Janjua","year":"2021","unstructured":"Janjua TI, Rewatkar P, Ahmed-Cox A, Saeed I, Mansfeld FM, Kulshreshtha R, et al. Frontiers in the treatment of glioblastoma: past, present and emerging. Adv Drug Deliv Rev. 2021. https:\/\/doi.org\/10.1016\/j.addr.2021.01.012.","journal-title":"Adv Drug Deliv Rev"},{"key":"4350_CR2","unstructured":"Stupp R, Mason WP, Van Den Bent MJ, Weller M, Fisher B, Taphoorn MJB, et al. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma [Internet]. www.nejm.org"},{"key":"4350_CR3","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3322\/caac.21613","volume":"70","author":"AC Tan","year":"2020","unstructured":"Tan AC, Ashley DM, L\u00f3pez GY, Malinzak M, Friedman HS, Khasraw M. Management of glioblastoma: state of the art and future directions. CA Cancer J Clin. 2020;70:299\u2013312. https:\/\/doi.org\/10.3322\/caac.21613.","journal-title":"CA Cancer J Clin"},{"key":"4350_CR4","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2019.1599662","author":"A Arora","year":"2019","unstructured":"Arora A, Somasundaram K. Glioblastoma vs temozolomide: can the red queen race be won? Cancer Biol Ther. 2019. https:\/\/doi.org\/10.1080\/15384047.2019.1599662.","journal-title":"Cancer Biol Ther"},{"key":"4350_CR5","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1002\/cncr.24950","volume":"116","author":"U Linz","year":"2010","unstructured":"Linz U. Commentary on effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial (Lancet Oncol. 2009;10:459\u2013466). Cancer [Internet]. 2010;116:1844\u20136. https:\/\/doi.org\/10.1002\/cncr.24950.","journal-title":"Cancer [Internet]"},{"key":"4350_CR6","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1124\/pr.117.014944","volume":"70","author":"A Shergalis","year":"2018","unstructured":"Shergalis A, Bankhead A, Luesakul U, Muangsin N, Neamati N. Current challenges and opportunities in treating glioblastoma. Pharmacol Rev. 2018;70:412\u201345. https:\/\/doi.org\/10.1124\/pr.117.014944.","journal-title":"Pharmacol Rev"},{"key":"4350_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11010005","author":"D Schiffer","year":"2019","unstructured":"Schiffer D, Annovazzi L, Casalone C, Corona C, Mellai M. Glioblastoma: Microenvironment and niche concept. Cancers (Basel). 2019. https:\/\/doi.org\/10.3390\/cancers11010005.","journal-title":"Cancers (Basel)."},{"key":"4350_CR8","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-1627","author":"W Tomaszewski","year":"2019","unstructured":"Tomaszewski W, Sanchez-Perez L, Gajewski TF, Sampson JH. Brain tumor microenvironment and host state: implications for immunotherapy. Clin Cancer Res. 2019. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-1627.","journal-title":"Clin Cancer Res"},{"key":"4350_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.656541","author":"N Zhang","year":"2021","unstructured":"Zhang N, Dai Z, Wu W, Wang Z, Cao H, Zhang Y, et al. The predictive value of monocytes in immune microenvironment and prognosis of glioma patients based on machine learning. Front Immunol. 2021. https:\/\/doi.org\/10.3389\/fimmu.2021.656541.","journal-title":"Front Immunol"},{"key":"4350_CR10","doi-asserted-by":"publisher","DOI":"10.1039\/d1cs00574j","author":"V Lenders","year":"2023","unstructured":"Lenders V, Koutsoumpou X, Phan P, Soenen SJ, Allegaert K, de Vleeschouwer S, et al. Modulation of engineered nanomaterial interactions with organ barriers for enhanced drug transport. Chem Soc Rev. 2023. https:\/\/doi.org\/10.1039\/d1cs00574j.","journal-title":"Chem Soc Rev"},{"key":"4350_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41563-021-01047-7","author":"I de L\u00e1zaro","year":"2021","unstructured":"de L\u00e1zaro I, Mooney DJ. Obstacles and opportunities in a forward vision for cancer nanomedicine. Nat Mater. 2021. https:\/\/doi.org\/10.1038\/s41563-021-01047-7.","journal-title":"Nat Mater"},{"key":"4350_CR12","doi-asserted-by":"publisher","DOI":"10.1039\/d0na00478b","author":"V Lenders","year":"2020","unstructured":"Lenders V, Koutsoumpou X, Sargsian A, Manshian BB. Biomedical nanomaterials for immunological applications: ongoing research and clinical trials. Nanoscale Adv. 2020. https:\/\/doi.org\/10.1039\/d0na00478b.","journal-title":"Nanoscale Adv"},{"key":"4350_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/natrevmats.2016.14","author":"S Wilhelm","year":"2016","unstructured":"Wilhelm S, Tavares AJ, Dai Q, Ohta S, Audet J, Dvorak HF, et al. Analysis of nanoparticle delivery to tumours. Nat Rev Mater. 2016. https:\/\/doi.org\/10.1038\/natrevmats.2016.14.","journal-title":"Nat Rev Mater"},{"key":"4350_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03572-y","author":"S Yuan","year":"2025","unstructured":"Yuan S, Hu D, Gao D, Butch CJ, Wang Y, Zheng H, et al. Recent advances of engineering cell membranes for nanomedicine delivery across the blood\u2013brain barrier. J Nanobiotechnol. 2025. https:\/\/doi.org\/10.1186\/s12951-025-03572-y.","journal-title":"J Nanobiotechnol"},{"key":"4350_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202004346","author":"Y Duan","year":"2020","unstructured":"Duan Y, Wu M, Hu D, Pan Y, Hu F, Liu X, et al. Biomimetic nanocomposites cloaked with bioorthogonally labeled glioblastoma cell membrane for targeted multimodal imaging of brain tumors. Adv Funct Mater. 2020. https:\/\/doi.org\/10.1002\/adfm.202004346.","journal-title":"Adv Funct Mater"},{"key":"4350_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-021-01110-0","author":"W Hao","year":"2021","unstructured":"Hao W, Cui Y, Fan Y, Chen M, Yang G, Wang Y, et al. Hybrid membrane-coated nanosuspensions for multi-modal anti-glioma therapy via drug and antigen delivery. J Nanobiotechnol. 2021. https:\/\/doi.org\/10.1186\/s12951-021-01110-0.","journal-title":"J Nanobiotechnol"},{"key":"4350_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/bmm2.12110","author":"S Zheng","year":"2024","unstructured":"Zheng S, Li X, Guo S. Nanomedicine hitchhiking on bacteria for treating tumors. BMEMat. 2024. https:\/\/doi.org\/10.1002\/bmm2.12110.","journal-title":"BMEMat"},{"key":"4350_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01544-0","author":"V Lenders","year":"2022","unstructured":"Lenders V, Escudero R, Koutsoumpou X, Armengol\u00c1lvarez L, Rozenski J, Soenen SJ, et al. Modularity of RBC hitchhiking with polymeric nanoparticles: testing the limits of non-covalent adsorption. J Nanobiotechnol. 2022. https:\/\/doi.org\/10.1186\/s12951-022-01544-0.","journal-title":"J Nanobiotechnol"},{"key":"4350_CR19","doi-asserted-by":"publisher","DOI":"10.20517\/cdr.2020.55","author":"S Yaman","year":"2020","unstructured":"Yaman S, Chintapula U, Rodriguez E, Ramachandramoorthy H, Nguyen KT. Cell-mediated and cell membrane-coated nanoparticles for drug delivery and cancer therapy. Cancer Drug Resist. 2020. https:\/\/doi.org\/10.20517\/cdr.2020.55.","journal-title":"Cancer Drug Resist"},{"key":"4350_CR20","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1080\/10717544.2020.1831103","volume":"27","author":"H Yu","year":"2020","unstructured":"Yu H, Yang Z, Li F, Xu L, Sun Y. Cell-mediated targeting drugs delivery systems. Drug Deliv. 2020;27:1425\u201337. https:\/\/doi.org\/10.1080\/10717544.2020.1831103.","journal-title":"Drug Deliv"},{"key":"4350_CR21","doi-asserted-by":"publisher","first-page":"13333","DOI":"10.1021\/acsnano.3c01428","volume":"17","author":"J Kuang","year":"2023","unstructured":"Kuang J, Rao ZY, Zheng DW, Kuang D, Huang QX, Pan T, et al. Nanoparticles hitchhike on monocytes for glioblastoma treatment after low-dose radiotherapy. ACS Nano. 2023;17:13333\u201347. https:\/\/doi.org\/10.1021\/acsnano.3c01428.","journal-title":"ACS Nano"},{"key":"4350_CR22","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jconrel.2014.03.050","volume":"190","author":"AC Anselmo","year":"2014","unstructured":"Anselmo AC, Mitragotri S. Cell-mediated delivery of nanoparticles: taking advantage of circulatory cells to target nanoparticles. J Control Release [Internet]. 2014;190:531\u201341. https:\/\/doi.org\/10.1016\/j.jconrel.2014.03.050.","journal-title":"J Control Release [Internet]"},{"key":"4350_CR23","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1166\/jbn.2020.2881","volume":"16","author":"P Allavena","year":"2020","unstructured":"Allavena P, Palmioli A, Avigni R, Sironi M, La Ferla B, Maeda A. PLGA based nanoparticles for the monocyte-mediated anti-tumor drug delivery system. J Biomed Nanotechnol. 2020;16:212\u201323. https:\/\/doi.org\/10.1166\/jbn.2020.2881.","journal-title":"J Biomed Nanotechnol"},{"key":"4350_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202400925","author":"C Li","year":"2024","unstructured":"Li C, Niu C, Chen L, Yu B, Luo F, Qie J, et al. Classical monocytes shuttling for precise delivery of nanotherapeutics to glioblastoma. Adv Healthc Mater. 2024. https:\/\/doi.org\/10.1002\/adhm.202400925.","journal-title":"Adv Healthc Mater"},{"key":"4350_CR25","doi-asserted-by":"publisher","DOI":"10.2217\/nnm-2017-0266","author":"C Wang","year":"2018","unstructured":"Wang C, Li K, Li T, Chen Z, Wen Y, Liu X, et al. Monocyte-mediated chemotherapy drug delivery in glioblastoma. Nanomedicine. 2018. https:\/\/doi.org\/10.2217\/nnm-2017-0266.","journal-title":"Nanomedicine"},{"key":"4350_CR26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jconrel.2014.11.027","volume":"199","author":"AC Anselmo","year":"2015","unstructured":"Anselmo AC, Gilbert JB, Kumar S, Gupta V, Cohen RE, Rubner MF, et al. Monocyte-mediated delivery of polymeric backpacks to inflamed tissues: a generalized strategy to deliver drugs to treat inflammation. J Control Release [Internet]. 2015;199:29\u201336. https:\/\/doi.org\/10.1016\/j.jconrel.2014.11.027.","journal-title":"J Control Release [Internet]"},{"key":"4350_CR27","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41586-019-0993-x","volume":"567","author":"Y Shi","year":"2019","unstructured":"Shi Y, Lim SK, Liang Q, Iyer SV, Wang HY, Wang Z, et al. Gboxin is an oxidative phosphorylation inhibitor that targets glioblastoma. Nature. 2019;567:341\u20136. https:\/\/doi.org\/10.1038\/s41586-019-0993-x.","journal-title":"Nature"},{"key":"4350_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-023-02843-6","author":"S Qu","year":"2023","unstructured":"Qu S, Qi S, Zhang H, Li Z, Wang K, Zhu T, et al. Albumin-bound paclitaxel augment temozolomide treatment sensitivity of glioblastoma cells by disrupting DNA damage repair and promoting ferroptosis. J Exp Clin Cancer Res. 2023. https:\/\/doi.org\/10.1186\/s13046-023-02843-6.","journal-title":"J Exp Clin Cancer Res"},{"key":"4350_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/nano6020026","author":"Y Wang","year":"2016","unstructured":"Wang Y, Li P, Tran TTD, Zhang J, Kong L. Manufacturing techniques and surface engineering of polymer based nanoparticles for targeted drug delivery to cancer. Nanomaterials. 2016. https:\/\/doi.org\/10.3390\/nano6020026.","journal-title":"Nanomaterials"},{"key":"4350_CR30","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1080\/1061186X.2019.1567738","volume":"27","author":"LP Ganipineni","year":"2019","unstructured":"Ganipineni LP, Ucakar B, Joudiou N, Riva R, J\u00e9r\u00f4me C, Gallez B, et al. Paclitaxel-loaded multifunctional nanoparticles for the targeted treatment of glioblastoma. J Drug Target [Internet]. 2019;27:614\u201323. https:\/\/doi.org\/10.1080\/1061186X.2019.1567738.","journal-title":"J Drug Target [Internet]"},{"key":"4350_CR31","unstructured":"Xu Y, Shen M, Li Y, Sun Y, Teng Y, Wang Y, et al. The synergic antitumor effects of paclitaxel and temozolomide co-loaded in mPEG-PLGA nanoparticles on glioblastoma cells [Internet]. www.impactjournals.com\/oncotarget"},{"key":"4350_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-68017-y","author":"M Norouzi","year":"2020","unstructured":"Norouzi M, Yathindranath V, Thliveris JA, Kopec BM, Siahaan TJ, Miller DW. Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles. Sci Rep. 2020. https:\/\/doi.org\/10.1038\/s41598-020-68017-y.","journal-title":"Sci Rep"},{"key":"4350_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08972-5","author":"MTC Poon","year":"2021","unstructured":"Poon MTC, Bruce M, Simpson JE, Hannan CJ, Brennan PM. Temozolomide sensitivity of malignant glioma cell lines \u2013 a systematic review assessing consistencies between in vitro studies. BMC Cancer. 2021. https:\/\/doi.org\/10.1186\/s12885-021-08972-5.","journal-title":"BMC Cancer"},{"key":"4350_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-10643-9","author":"K Cho","year":"2022","unstructured":"Cho K, Choi ES, Kim JH, Son JW, Kim E. Numerical learning of deep features from drug-exposed cell images to calculate IC50 without staining. Sci Rep. 2022. https:\/\/doi.org\/10.1038\/s41598-022-10643-9.","journal-title":"Sci Rep"},{"key":"4350_CR35","unstructured":"Ruan D, Li X, Li A, Liu B, Xu F. Paclitaxel inhibits growth and proliferation of glioblastoma through MMP-9-meidated p38\/JNK signaling pathway [Internet]. www.biomedres.info"},{"key":"4350_CR36","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1021\/acs.bioconjchem.0c00078","volume":"31","author":"C Maksoudian","year":"2020","unstructured":"Maksoudian C, Soenen SJ, Susumu K, Oh E, Medintz IL, Manshian BB. A multiparametric evaluation of quantum dot size and surface-grafted peptide density on cellular uptake and cytotoxicity. Bioconjug Chem. 2020;31:1077\u201387. https:\/\/doi.org\/10.1021\/acs.bioconjchem.0c00078.","journal-title":"Bioconjug Chem"},{"key":"4350_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12645-021-00084-w","author":"YL Lo","year":"2021","unstructured":"Lo YL, Lin HC, Hong ST, Chang CH, Wang CS, Lin AMY. Lipid polymeric nanoparticles modified with tight junction-modulating peptides promote afatinib delivery across a blood\u2013brain barrier model. Cancer Nanotechnol. 2021. https:\/\/doi.org\/10.1186\/s12645-021-00084-w.","journal-title":"Cancer Nanotechnol"},{"key":"4350_CR38","doi-asserted-by":"crossref","unstructured":"Gaillard PJ, Gerrit De Boer A. Relationship between permeability status of the blood-brain barrier and in vitro permeability coefficient of a drug [Internet]. European Journal of Pharmaceutical Sciences. 2000. www.elsevier.nl\/locate\/ejps","DOI":"10.1016\/S0928-0987(00)00152-4"},{"key":"4350_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0219632","author":"MC Garrett","year":"2020","unstructured":"Garrett MC, O\u2019Shea TM, Wollenberg AL, Bernstein AM, Hung D, Staarman B, et al. Injectable diblock copolypeptide hydrogel provides platform to deliver effective concentrations of paclitaxel to an intracranial xenograft model of glioblastoma. PLoS ONE. 2020. https:\/\/doi.org\/10.1371\/journal.pone.0219632.","journal-title":"PLoS ONE"},{"key":"4350_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1076958","author":"J Lu","year":"2022","unstructured":"Lu J, Xu F, Rao C, Shen C, Jin J, Zhu Z, et al. Mechanism of action of paclitaxel for treating glioblastoma based on single-cell RNA sequencing data and network pharmacology. Front Pharmacol. 2022. https:\/\/doi.org\/10.3389\/fphar.2022.1076958.","journal-title":"Front Pharmacol"},{"key":"4350_CR41","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jconrel.2008.09.086","volume":"133","author":"F Danhier","year":"2009","unstructured":"Danhier F, Lecouturier N, Vroman B, J\u00e9r\u00f4me C, Marchand-Brynaert J, Feron O, et al. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation. J Control Release. 2009;133:11\u20137. https:\/\/doi.org\/10.1016\/j.jconrel.2008.09.086.","journal-title":"J Control Release"},{"key":"4350_CR42","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.colsurfb.2019.06.035","volume":"181","author":"Q Shuai","year":"2019","unstructured":"Shuai Q, Zhao G, Zhang X, Yu B, Lee RJ, Su WK. Selection of fluorescent dye for tracking biodistribution of paclitaxel in live imaging. Colloids Surf B Biointerfaces. 2019;181:872\u20138. https:\/\/doi.org\/10.1016\/j.colsurfb.2019.06.035.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"4350_CR43","doi-asserted-by":"publisher","first-page":"32159","DOI":"10.1021\/acsami.6b10175","volume":"8","author":"Y Cui","year":"2016","unstructured":"Cui Y, Zhang M, Zeng F, Jin H, Xu Q, Huang Y. Dual-targeting magnetic PLGA nanoparticles for codelivery of paclitaxel and curcumin for brain tumor therapy. ACS Appl Mater Interfaces. 2016;8:32159\u201369. https:\/\/doi.org\/10.1021\/acsami.6b10175.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4350_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05139-3","author":"J Clusmann","year":"2022","unstructured":"Clusmann J, Franco KDC, Su\u00e1rez DAC, Katona I, Minguez MG, Boersch N, et al. Acidosis induces RIPK1-dependent death of glioblastoma stem cells via acid-sensing ion channel 1a. Cell Death Dis. 2022. https:\/\/doi.org\/10.1038\/s41419-022-05139-3.","journal-title":"Cell Death Dis"},{"key":"4350_CR45","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1002\/nbm.3578","volume":"29","author":"Y Huang","year":"2016","unstructured":"Huang Y, Coman D, Herman P, Rao JU, Maritim S, Hyder F. Towards longitudinal mapping of extracellular pH in gliomas. NMR Biomed. 2016;29:1364\u201372. https:\/\/doi.org\/10.1002\/nbm.3578.","journal-title":"NMR Biomed"},{"key":"4350_CR46","doi-asserted-by":"publisher","first-page":"8398","DOI":"10.1021\/acs.analchem.9b01250","volume":"91","author":"SS Li","year":"2019","unstructured":"Li SS, Zhang M, Wang JH, Yang F, Kang B, Xu JJ, et al. Monitoring the changes of pH in lysosomes during autophagy and apoptosis by plasmon enhanced raman imaging. Anal Chem. 2019;91:8398\u2013405. https:\/\/doi.org\/10.1021\/acs.analchem.9b01250.","journal-title":"Anal Chem"},{"key":"4350_CR47","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jconrel.2007.05.034","volume":"122","author":"BS Zolnik","year":"2007","unstructured":"Zolnik BS, Burgess DJ. Effect of acidic pH on PLGA microsphere degradation and release. J Control Release. 2007;122:338\u201344. https:\/\/doi.org\/10.1016\/j.jconrel.2007.05.034.","journal-title":"J Control Release"},{"key":"4350_CR48","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jconrel.2007.01.009","volume":"119","author":"U Westedt","year":"2007","unstructured":"Westedt U, Kalinowski M, Wittmar M, Merdan T, Unger F, Fuchs J, et al. Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment. J Control Release. 2007;119:41\u201351. https:\/\/doi.org\/10.1016\/j.jconrel.2007.01.009.","journal-title":"J Control Release"},{"key":"4350_CR49","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/684071","author":"FC Liu","year":"2013","unstructured":"Liu FC, Pan CH, Lai MT, Chang SJ, Chung JG, Wu CH. Gan-Lu-Yin inhibits proliferation and migration of murine WEHI-3 leukemia cells and tumor growth in BALB\/C allograft tumor model. Evid-Based Complement Altern Med. 2013. https:\/\/doi.org\/10.1155\/2013\/684071.","journal-title":"Evid-Based Complement Altern Med"},{"key":"4350_CR50","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S479270","author":"KW Ho","year":"2024","unstructured":"Ho KW, Liu YL, Liao TY, Liu ES, Cheng TL. Strategies for non-covalent attachment of antibodies to PEGylated nanoparticles for targeted drug delivery. Int J Nanomed. 2024. https:\/\/doi.org\/10.2147\/IJN.S479270.","journal-title":"Int J Nanomed"},{"key":"4350_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/nri3070","author":"C Shi","year":"2011","unstructured":"Shi C, Pamer EG. Monocyte recruitment during infection and inflammation. Nat Rev Immunol. 2011. https:\/\/doi.org\/10.1038\/nri3070.","journal-title":"Nat Rev Immunol"},{"key":"4350_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17101350","author":"JW Lee","year":"2025","unstructured":"Lee JW, Park JH, Yu GW, You JW, Han MJ, Kang MJ, et al. Sustained-release intra-articular drug delivery: PLGA systems in clinical context and evolving strategies. Pharmaceutics. 2025. https:\/\/doi.org\/10.3390\/pharmaceutics17101350.","journal-title":"Pharmaceutics"},{"key":"4350_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2020.07.007","author":"S Trzebanski","year":"2020","unstructured":"Trzebanski S, Jung S. Plasticity of monocyte development and monocyte fates. Immunol Lett. 2020. https:\/\/doi.org\/10.1016\/j.imlet.2020.07.007.","journal-title":"Immunol Lett"},{"key":"4350_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-71857-3","author":"K Shono","year":"2020","unstructured":"Shono K, Yamaguchi I, Mizobuchi Y, Kagusa H, Sumi A, Fujihara T, et al. Downregulation of the CCL2\/CCR2 and CXCL10\/CXCR3 axes contributes to antitumor effects in a mouse model of malignant glioma. Sci Rep. 2020. https:\/\/doi.org\/10.1038\/s41598-020-71857-3.","journal-title":"Sci Rep"},{"key":"4350_CR55","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/cei.12579","volume":"180","author":"D Petrovic-Djergovic","year":"2015","unstructured":"Petrovic-Djergovic D, Popovic M, Chittiprol S, Cortado H, Ransom RF, Partida-S\u00e1nchez S. CXCL10 induces the recruitment of monocyte-derived macrophages into kidney, which aggravate puromycin aminonucleoside nephrosis. Clin Exp Immunol. 2015;180:305\u201315. https:\/\/doi.org\/10.1111\/cei.12579.","journal-title":"Clin Exp Immunol"},{"key":"4350_CR56","doi-asserted-by":"crossref","unstructured":"Piao Y, Henry V, Tiao N, Park SY, Martinez-Ledesma J, Dong JW, et al. Oncotarget 96970 www.impactjournals.com\/oncotarget Targeting intercellular adhesion molecule-1 prolongs survival in mice bearing bevacizumab-resistant glioblastoma [Internet]. Oncotarget. 2017. www.impactjournals.com\/oncotarget\/","DOI":"10.18632\/oncotarget.18859"},{"key":"4350_CR57","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/imm.13490","volume":"167","author":"R Feldtmann","year":"2022","unstructured":"Feldtmann R, K\u00fcmmel A, Chamling B, Strohbach A, Lehnert K, Gross S, et al. Myeloid differentiation factor-2 activates monocytes in patients with dilated cardiomyopathy. Immunology. 2022;167:40\u201353. https:\/\/doi.org\/10.1111\/imm.13490.","journal-title":"Immunology"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04350-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04350-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04350-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T02:27:20Z","timestamp":1781058440000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04350-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4350"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04350-0","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"12 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments and research procedures were conducted in accordance with the declaration of Helsinki and EU Directive 2010\/63\/EU on the protection and welfare of animals used for scientific research. These experiments were approved by the Institutional Animal Care and Research Advisory Committee (KU Leuven) (ECD number: 199\/2021).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"540"}}